Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare Co is the largest provider of behavioral healthcare services in the United States, with a network of 239 facilities and over 10,000 beds in 39 states and Puerto Rico. Its strong same-facility admissions, ongoing reorganization efforts, and improvement in payor denials signal positive momentum for the company. While its dependence on a few key states and potential risks from government investigations may pose concerns, our analysis suggests a solid outlook for Acadia's financials and operations.

Acadia Healthcare Co is facing multiple risks, including potential impacts to Medicaid funding and reimbursement pressure, slower-than-expected ramping of newly-added beds, and potential media and regulatory scrutiny. However, the company's recent EBITDA upside, focus on improving its cash flow profile and execution in ramping its facilities, and promising position in the growing behavioral health marketplace support a positive outlook. Based on its current performance, a BUY rating and a PT of $31 (from $26) is maintained, representing a target multiple of ~8.5x (from ~8x) and acknowledging the potential for a ~0.5x multiple expansion. However, a downside scenario could yield a valuation of approximately $15 if softness in volumes persists and the forward enterprise multiple contracts to 7.0x. Market concentration, reimbursement, government investigations, improper admission practices, execution on de novo development and labor market challenges all pose risks to Acadia's business and its PT, which has been raised from $20 to $30.